New CEO of Senzime

Uppsala, May 3, 2023. Senzime AB (publ) hereby announces that the company's board of directors has decided to appoint Philip Siberg, currently chairman of the board, as the new CEO. Philip takes up his new role immediately and thus replaces Pia Renaudin who has been CEO since February 2019.

Philip Siberg has been chairman of Senzime since 2016 when the company acquired Acacia Designs BV, which Philip was the CEO of. Acacia Designs pioneered the development of the TetraGraph system based on research from Mayo Clinic in the USA, and it’s today Senzime’s main line of business. Philip has solid experience from various CEO and chairman roles within the Life Science industry and especially commercialization of innovations in the US healthcare market. By the appointment of Philip, the Board believes that Senzime has increased chances to succeed with the commercialization that has rapidly commenced in the US, and Philip brings in deep insights into Senzime's product offering, organization, and market.

"I am very honored to be trusted to take on the role of CEO of Senzime. The company has a fantastic product portfolio, organization and market position which is now facing a powerful global growth journey”, said Philip Siberg.

The board would like to express a big thank you to Pia Renaudin for her wholehearted efforts as CEO of Senzime – not least during the COVID-19 pandemic when Senzime managed to carry out a global launch and show sales growth despite extremely difficult market conditions. Pia has worked hard and has been a strong contributor to taking Senzime to the very exciting position the company is in today including recently communicated rapid growth rate.

Adam Dahlberg succeeds Philip Siberg as chairman of the board. Adam is a member of the Crafoord family and thus represents Senzime's largest owner and a more than 20-year commitment to the company.

Contact us

Want to know more?

How can Senzime’s innovative patient monitoring solutions help to eliminate in-hospital complications?
Contact us today.